Recent Publications

Home / RDI / Recent Publications

The existing research evidence register contains 11 selected coauthored publications within 10 September 2024–10 September 2026. They show the subjects and study approaches represented in the group’s recent scientific work. Titles below are shortened; each title links to its DOI.

IDPublication focus / journalYear / study type
P01GSK-3β, adipose dysfunction and cardiovascular complications
The FASEB Journal		2024
Review
P02DPP-4/SGLT2 inhibitors, cognition and metabolomic mechanisms in type 2 diabetes
Biomedicine & Pharmacotherapy		2024 online; 2025 issue
Human observational study
P03Neurovascular coupling, astrocytes and GPCRs in Alzheimer’s disease
ACS Pharmacology & Translational Science		2025
Review
P04Multi-target thiazolones for metabolic disease-associated portal inflammation
European Journal of Medicinal Chemistry		2025
Preclinical research
P05Fermented-milk bioactive peptides: health implications and AI integration
Food Chemistry		2025
Review; metadata-only record
P06Multi-target glitazones: PPARγ, COX-2 and carbonic anhydrases
ACS Pharmacology & Translational Science		2025
Preclinical research
P07Serum proteome profiling in diabetes treated with DPP4 and SGLT2 inhibitors
PROTEOMICS		2025
Human serum proteomics
P08Furanone-based anticancer agents: Hsp90 and pharmacokinetic investigation
European Journal of Medicinal Chemistry		2025
Preclinical; metadata-only record
P09Repurposing SGLT2/DPP-4 inhibitors for mild cognitive impairment
British Journal of Pharmacology		2026
Human observational and mechanistic research
P10Organophosphates, endocannabinoid signalling and neuroinflammation
Basic & Clinical Pharmacology & Toxicology		2026
Review
P11Hippocampal mitochondrial and synaptic changes with organophosphates and pre-diabetes
Biomolecules		2026
Animal proteomics study